169 related articles for article (PubMed ID: 17935664)
21. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.
Rayner HC; Haynes AP; Thompson JR; Russell N; Fletcher J
Q J Med; 1991 Jun; 79(290):517-25. PubMed ID: 1946932
[TBL] [Abstract][Full Text] [Related]
22. [Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors].
Zdziarska B
Ann Acad Med Stetin; 1990; 36():179-94. PubMed ID: 2099106
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival patients with acute and severe renal failure due to multiple myeloma.
Pasquali S; Casanova S; Zucchelli A; Zucchelli P
Clin Nephrol; 1990 Dec; 34(6):247-54. PubMed ID: 2073767
[TBL] [Abstract][Full Text] [Related]
24. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
Kraj M; Maj S; Pogłód R; Rostkowska J
Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
Scudla V; Vavrdová V; Budíková M; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
[TBL] [Abstract][Full Text] [Related]
27. [Multiple myeloma: epidemiologic and clinical considerations].
Pasqualetti P; Collacciani A; Colantonio D; Casale R
G Ital Oncol; 1990; 10(3):71-6. PubMed ID: 2286395
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and staging in multiple myeloma: a reappraisal.
Bataille R; Durie BG; Grenier J; Sany J
J Clin Oncol; 1986 Jan; 4(1):80-7. PubMed ID: 3510284
[TBL] [Abstract][Full Text] [Related]
29. [Reproducibility of a mathematical model for calculating survival in multiple myeloma].
Pasqualetti P; Casale R; Colantonio D
Medicina (Firenze); 1989; 9(2):182-4. PubMed ID: 2811644
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in myeloma. Step-by-step regression analysis (Cox method)].
López Pascual J; García Ahumada F; Montero J; Fernández-Rañada JM
Rev Clin Esp; 1987 Apr; 180(7):357-63. PubMed ID: 3602548
[No Abstract] [Full Text] [Related]
31. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
[TBL] [Abstract][Full Text] [Related]
32. [Socioeconomic status and survival in multiple myeloma].
Pasqualetti P; Colantonio D; Collacciani A; Casale R
Minerva Med; 1990 Oct; 81(10):713-6. PubMed ID: 2234467
[TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma: prognostic factors and treatment modalities.
Michiels JJ
Neth J Med; 1992 Jun; 40(5-6):254-70. PubMed ID: 1436263
[No Abstract] [Full Text] [Related]
34. Additional predictive value of serum unsaturated vitamin B12 proteins in multiple myeloma.
Arnalich F; Zamorano AF; Martinez-Hernández P; Pena JM; Barbado FJ; Vázquez JJ
J Med; 1990; 21(5):277-86. PubMed ID: 2079617
[TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma in two young postpartum women.
Harster GA; Krause JR
Arch Pathol Lab Med; 1987 Jan; 111(1):38-42. PubMed ID: 3800603
[TBL] [Abstract][Full Text] [Related]
36. The Merlini, Waldenström, Jayakar staging system revisited.
Merlini G; Gobbi PG; Ascari E
Eur J Haematol Suppl; 1989; 51():105-10. PubMed ID: 2697581
[TBL] [Abstract][Full Text] [Related]
37. Prognostic variables and clinical staging in multiple myeloma.
Cavo M; Galieni P; Zuffa E; Baccarani M; Gobbi M; Tura S
Blood; 1989 Oct; 74(5):1774-80. PubMed ID: 2790201
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy of multiple bone myeloma. Prognostic features and response criteria (First part) (author's transl)].
Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
Sem Hop; 1979 Sep 8-15; 55(27-30):1267-70. PubMed ID: 228397
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in multiple myeloma: a new staging system based on clinical and morphological features.
Pasqualetti P; Casale R; Collacciani A; Colantonio D
Eur J Cancer; 1991; 27(9):1123-6. PubMed ID: 1835621
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and classification in multiple myeloma.
San Miguel JF; Sànchez J; Gonzalez M
Br J Cancer; 1989 Jan; 59(1):113-8. PubMed ID: 2757917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
